Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05BA18
CAS registry number (Chemical Abstracts Service)
0029177-84-2
Chemical Formula
C18-H14-Cl-F-N2-O3
Molecular Weight
361
Therapeutic Category
Anxiolytic agent
Chemical Name
1H-1,4-Benzodiazepin-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, etyl ester
Foreign Names
- Ethylis loflazepas (Latin)
- Ethyl loflazepat (German)
- Loflazépate d'éthyle (French)
- Loflazepato de etilo (Spanish)
Generic Names
- Ethyl Loflazepate (OS: JAN)
- Loflazépate d'éthyle (OS: DCF)
- CM 6912 (Sanofi) (IS)
Brand Names
- Demethox
Nichi-Iko Pharmaceutical, Japan - Ethyl Loflazepate Sawai
Sawai Seiyaku, Japan - Ethyl Loflazepate Towa
Towa Yakuhin, Japan - Meilax
Meiji, China; Meiji Seika Pharma, Japan - Meilax 1%
Meiji Seika Pharma, Japan - Ronlax
Shiono Kemikaru, Japan - Sukarnase
Towa Yakuhin, Japan - Victan
Sanofi, Dominican Republic; Sanofi, Guatemala; Sanofi, Panama; Sanofi Belgium, Belgium; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, France; Sanofi-Aventis, Honduras; Sanofi-Aventis, Mexico; Sanofi-Aventis, Portugal; Sanofi-Aventis, Paraguay; Sanofi-Aventis, El Salvador; Sintofarm, Romania - Victan 2mg
Sanofi Belgium, Luxembourg
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.